Development of a meningococcal vaccine.

作者信息

Poolman J T

机构信息

Laboratory of Vaccine Development and Immune Mechanisms, National Institute of Public Health and Environmental Protection, Bilthoven, The Netherlands.

出版信息

Infect Agents Dis. 1995 Mar;4(1):13-28.

PMID:7728353

Abstract

摘要

相似文献

Development of a meningococcal vaccine.

Infect Agents Dis. 1995 Mar;4(1):13-28.

Vaccines against meningococcal meningitis: current status.抗脑膜炎球菌性脑膜炎疫苗：现状

Epidemiol Bull. 1994 Jul;15(2):13-5.

Production, characterization and control of MenB-vaccine "Folkehelsa": an outer membrane vesicle vaccine against group B meningococcal disease.B群脑膜炎球菌疫苗“Folkehelsa”的生产、特性及控制：一种针对B群脑膜炎球菌病的外膜囊泡疫苗

NIPH Ann. 1991 Dec;14(2):67-79; discussion 79-80.

Second generation meningococcal OMP-LPS vaccines.

NIPH Ann. 1991 Dec;14(2):233-41.

[Vaccines against Neisseria meningitidis].[抗脑膜炎奈瑟菌疫苗]

Enferm Infecc Microbiol Clin. 1992 May;10(5):296-301.

Polysaccharides and membrane vaccines.多糖疫苗和膜疫苗。

Adv Biotechnol Processes. 1990;13:57-86.

[Meningococcal meningitis: preliminary epidemiological results on the introduction of a prophylactic vaccine].[脑膜炎球菌性脑膜炎：引入预防性疫苗后的初步流行病学结果]

G Batteriol Virol Immunol. 1982 Jul-Dec;75(7-12):251-4.

Meningococcal meningitis.

Lancet. 1989 Mar 25;1(8639):647-8.

Meningococcal vaccines.脑膜炎球菌疫苗

Expert Rev Vaccines. 2002 Jun;1(1):75-84. doi: 10.1586/14760584.1.1.75.

Status of a group B Neisseria meningitidis vaccine.B 群脑膜炎奈瑟菌疫苗的现状

Eur J Clin Microbiol. 1985 Dec;4(6):533-6. doi: 10.1007/BF02013388.

引用本文的文献

Neutralization of Neisseria meningitidis outer membrane vesicles.脑膜炎奈瑟菌外膜囊泡的中和作用。

Inflamm Res. 2011 Sep;60(9):801-5. doi: 10.1007/s00011-011-0344-3. Epub 2011 May 24.

Structural Basis for the Immunogenic Properties of the Meningococcal Vaccine Candidate LP2086.脑膜炎球菌疫苗候选物LP2086免疫原性的结构基础

J Biol Chem. 2009 Mar 27;284(13):8738-46. doi: 10.1074/jbc.M808831200. Epub 2008 Dec 22.

Pathogen proteins eliciting antibodies do not share epitopes with host proteins: a bioinformatics approach.病原体蛋白诱导的抗体不与宿主蛋白共享表位：一种生物信息学方法。

PLoS One. 2007 Jun 6;2(6):e512. doi: 10.1371/journal.pone.0000512.

Mucosal vaccination against serogroup B meningococci: induction of bactericidal antibodies and cellular immunity following intranasal immunization with NadA of Neisseria meningitidis and mutants of Escherichia coli heat-labile enterotoxin.针对B群脑膜炎奈瑟菌的黏膜疫苗接种：用脑膜炎奈瑟菌NadA和大肠杆菌不耐热肠毒素突变体经鼻免疫后诱导杀菌抗体和细胞免疫。

Infect Immun. 2004 Jul;72(7):4052-60. doi: 10.1128/IAI.72.7.4052-4060.2004.

Vaccine potential of the Neisseria meningitidis 2086 lipoprotein.脑膜炎奈瑟菌2086脂蛋白的疫苗潜力

Infect Immun. 2004 Apr;72(4):2088-100. doi: 10.1128/IAI.72.4.2088-2100.2004.

NadA, a novel vaccine candidate of Neisseria meningitidis.NadA，一种新型的脑膜炎奈瑟菌疫苗候选物。

J Exp Med. 2002 Jun 3;195(11):1445-54. doi: 10.1084/jem.20020407.

Modification of lipid A biosynthesis in Neisseria meningitidis lpxL mutants: influence on lipopolysaccharide structure, toxicity, and adjuvant activity.脑膜炎奈瑟菌lpxL突变体中脂多糖A生物合成的修饰：对脂多糖结构、毒性和佐剂活性的影响。

Infect Immun. 2001 Oct;69(10):5981-90. doi: 10.1128/IAI.69.10.5981-5990.2001.

Neisseria meningitidis lipopolysaccharide modulates the specific humoral immune response to neisserial porins but has no effect on porin-induced upregulation of costimulatory ligand B7-2.脑膜炎奈瑟菌脂多糖调节针对奈瑟菌孔蛋白的特异性体液免疫反应，但对孔蛋白诱导的共刺激配体B7-2上调无影响。

Infect Immun. 2001 Aug;69(8):5031-6. doi: 10.1128/IAI.69.8.5031-5036.2001.

Functional activities and immunoglobulin variable regions of human and murine monoclonal antibodies specific for the P1.7 PorA protein loop of Neisseria meningitidis.针对脑膜炎奈瑟菌P1.7 PorA蛋白环的人源和鼠源单克隆抗体的功能活性及免疫球蛋白可变区

Infect Immun. 2000 Apr;68(4):1871-8. doi: 10.1128/IAI.68.4.1871-1878.2000.

Update on meningococcal disease with emphasis on pathogenesis and clinical management.脑膜炎球菌病最新进展，重点关注发病机制与临床管理。

Clin Microbiol Rev. 2000 Jan;13(1):144-66, table of contents. doi: 10.1128/CMR.13.1.144.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验